Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Meat intake, cooking methods and doneness and risk of colorectal tumours in the Spanish multicase-control study (MCC-Spain).

de Batlle J, Gracia-Lavedan E, Romaguera D, Mendez M, Castaño-Vinyals G, Martín V, Aragonés N, Gómez-Acebo I, Olmedo-Requena R, Jimenez-Moleon JJ, Guevara M, Azpiri M, Llorens-Ivorra C, Fernandez-Tardon G, Lorca JA, Huerta JM, Moreno V, Boldo E, Pérez-Gómez B, Castilla J, Fernández-Villa T, Barrio JP, Andreu M, Castells A, Dierssen T, Altzibar JM, Kogevinas M, Pollán M, Amiano P.

Eur J Nutr. 2018 Mar;57(2):643-653. doi: 10.1007/s00394-016-1350-6. Epub 2016 Nov 24.

PMID:
27885555
2.

Delineating the Phenotypic Spectrum of the NTHL1-Associated Polyposis.

Belhadj S, Mur P, Navarro M, González S, Moreno V, Capellá G, Valle L.

Clin Gastroenterol Hepatol. 2017 Mar;15(3):461-462. doi: 10.1016/j.cgh.2016.09.153. Epub 2016 Oct 5. No abstract available.

PMID:
27720914
3.

Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.

Lope V, Fernández de Larrea N, Pérez-Gómez B, Martín V, Moreno V, Costas L, Longo F, Jiménez-Moleón JJ, Llorca J, Ascunce N, Peiró-Pérez R, Altzibar JM, Tardón A, Alguacil J, Navarro C, Sierra Á, Vega AB, Villafañe A, Castaño-Vinyals G, Kogevinas M, Pollán M, Aragonés N.

PLoS One. 2016 Oct 24;11(10):e0164620. doi: 10.1371/journal.pone.0164620. eCollection 2016.

4.

Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.

Rosato V, Tavani A, Gracia-Lavedan E, Guinó E, Castaño-Vinyals G, Villanueva CM, Kogevinas M, Polesel J, Serraino D, Pisa FE, Barbone F, Moreno V, La Vecchia C, Bosetti C.

Front Oncol. 2016 Oct 6;6:210. eCollection 2016.

5.

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.

Dierssen-Sotos T, Gómez-Acebo I, de Pedro M, Pérez-Gómez B, Servitja S, Moreno V, Amiano P, Fernandez-Villa T, Barricarte A, Tardon A, Diaz-Santos M, Peiro-Perez R, Marcos-Gragera R, Lope V, Gracia-Lavedan E, Alonso MH, Michelena-Echeveste MJ, Garcia-Palomo A, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J.

BMC Cancer. 2016 Aug 20;16(1):660. doi: 10.1186/s12885-016-2692-4.

6.

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.

Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Pérez-Gómez B, Lope V, Tusquets I, Alonso MH, Moreno V, Amiano P, Molina de la Torre AJ, Barricarte A, Tardon A, Camacho A, Peiro-Perez R, Marcos-Gragera R, Muñoz M, Michelena-Echeveste MJ, Ortega Valin L, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J.

PLoS One. 2016 Aug 10;11(8):e0159672. doi: 10.1371/journal.pone.0159672. eCollection 2016.

7.

Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.

Kehlet SN, Sanz-Pamplona R, Brix S, Leeming DJ, Karsdal MA, Moreno V.

Sci Rep. 2016 Jul 28;6:30599. doi: 10.1038/srep30599.

8.

False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.

Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V.

Eur J Cancer Prev. 2017 Sep;26(5):365-367. doi: 10.1097/CEJ.0000000000000281.

PMID:
27433880
9.

Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.

Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V; ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ Working Group.

Dig Liver Dis. 2016 Oct;48(10):1249-54. doi: 10.1016/j.dld.2016.06.011. Epub 2016 Jun 21.

PMID:
27378703
10.

Algorithmic methods to infer the evolutionary trajectories in cancer progression.

Caravagna G, Graudenzi A, Ramazzotti D, Sanz-Pamplona R, De Sano L, Mauri G, Moreno V, Antoniotti M, Mishra B.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4025-34. doi: 10.1073/pnas.1520213113. Epub 2016 Jun 28.

11.

Night shift work and stomach cancer risk in the MCC-Spain study.

Gyarmati G, Turner MC, Castaño-Vinyals G, Espinosa A, Papantoniou K, Alguacil J, Costas L, Pérez-Gómez B, Martin Sanchez V, Ardanaz E, Moreno V, Gómez-Acebo I, Fernández-Tardon G, Villanueva Ballester V, Capelo R, Chirlaque MD, Santibáñez M, Pollán M, Aragonés N, Kogevinas M.

Occup Environ Med. 2016 Aug;73(8):520-7. doi: 10.1136/oemed-2016-103597. Epub 2016 Jun 16.

12.

Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.

Cantariño N, Musulén E, Valero V, Peinado MA, Perucho M, Moreno V, Forcales SV, Douet J, Buschbeck M.

Mol Cancer Res. 2016 Sep;14(9):841-8. doi: 10.1158/1541-7786.MCR-16-0034. Epub 2016 Jun 8.

13.

Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.

Azuara D, Santos C, Lopez-Doriga A, Grasselli J, Nadal M, Sanjuan X, Marin F, Vidal J, Montal R, Moreno V, Bellosillo B, Argiles G, Elez E, Dienstmann R, Montagut C, Tabernero J, Capellá G, Salazar R.

Mol Cancer Ther. 2016 May;15(5):1106-12. doi: 10.1158/1535-7163.MCT-15-0820. Epub 2016 Apr 1.

14.

Endoscopic band ligation without resection in selected patients for small and superficial upper gastrointestinal tract lesions.

Ibáñez-Sanz G, Gornals JB, Rivas L, Salord S, Paúles MJ, Botargues JM, Galán M.

Rev Esp Enferm Dig. 2016 May;108(5):250-6. doi: 10.17235/reed.2016.4031/2015.

15.

Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.

Zeng C, Matsuda K, Jia WH, Chang J, Kweon SS, Xiang YB, Shin A, Jee SH, Kim DH, Zhang B, Cai Q, Guo X, Long J, Wang N, Courtney R, Pan ZZ, Wu C, Takahashi A, Shin MH, Matsuo K, Matsuda F, Gao YT, Oh JH, Kim S, Jung KJ, Ahn YO, Ren Z, Li HL, Wu J, Shi J, Wen W, Yang G, Li B, Ji BT; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Brenner H, Schoen RE, Küry S; Colorectal Transdisciplinary (CORECT) Study, Gruber SB, Schumacher FR, Stenzel SL; Colon Cancer Family Registry (CCFR), Casey G, Hopper JL, Jenkins MA, Kim HR, Jeong JY, Park JW, Tajima K, Cho SH, Kubo M, Shu XO, Lin D, Zeng YX, Zheng W.

Gastroenterology. 2016 Jun;150(7):1633-1645. doi: 10.1053/j.gastro.2016.02.076. Epub 2016 Mar 8.

16.

Colorectal cancer risk and nitrate exposure through drinking water and diet.

Espejo-Herrera N, Gràcia-Lavedan E, Boldo E, Aragonés N, Pérez-Gómez B, Pollán M, Molina AJ, Fernández T, Martín V, La Vecchia C, Bosetti C, Tavani A, Polesel J, Serraino D, Gómez Acebo I, Altzibar JM, Ardanaz E, Burgui R, Pisa F, Fernández-Tardón G, Tardón A, Peiró R, Navarro C, Castaño-Vinyals G, Moreno V, Righi E, Aggazzotti G, Basagaña X, Nieuwenhuijsen M, Kogevinas M, Villanueva CM.

Int J Cancer. 2016 Jul 15;139(2):334-46. doi: 10.1002/ijc.30083. Epub 2016 Apr 4.

17.

Spontaneous intramural esophageal dissection: an unusual onset of eosinophilic esophagitis.

Ibáñez-Sanz G, Rodríguez-Alonso L, Romero NM.

Rev Esp Enferm Dig. 2016 Mar;108(3):156-7.

18.

Mutanome and expression of immune response genes in microsatellite stable colon cancer.

Sanz-Pamplona R, Gil-Hoyos R, López-Doriga A, Alonso MH, Aussó S, Molleví DG, Santos C, Sanjuán X, Salazar R, Alemany R, Moreno V.

Oncotarget. 2016 Apr 5;7(14):17711-25. doi: 10.18632/oncotarget.7293.

19.

Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.

Mur P, Sánchez-Cuartielles E, Aussó S, Aiza G, Valdés-Mas R, Pineda M, Navarro M, Brunet J, Urioste M, Lázaro C, Moreno V, Capellá G, Puente XS, Valle L.

Sci Rep. 2016 Feb 8;6:20697. doi: 10.1038/srep20697. Erratum in: Sci Rep. 2016;6:23880. Elena, Sánchez-Cuartielles [corrected to Sánchez-Cuartielles, Elena];.

20.

Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia.

Casabonne D, Gracia E, Espinosa A, Bustamante M, Benavente Y, Robles C, Costas L, Alonso E, Gonzalez-Barca E, Tardón A, Dierssen-Sotos T, Vázquez EG, Aymerich M, Campo E, Jiménez-Moleón JJ, Marcos-Gragera R, Castaño-Vinyals G, Aragones N, Pollan M, Kogevinas M, Urtiaga C, Amiano P, Moreno V, de Sanjose S.

Eur J Nutr. 2017 Apr;56(3):1123-1133. doi: 10.1007/s00394-016-1162-8. Epub 2016 Feb 2.

PMID:
26838684

Supplemental Content

Loading ...
Support Center